CORRECTION article

Front. Physiol., 06 March 2023

Sec. Cell Physiology

Volume 14 - 2023 | https://doi.org/10.3389/fphys.2023.1163389

Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential

  • 1. Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States

  • 2. Department of Biochemistry, University of Bayreuth, Bayreuth, Germany

  • 3. Tri-Institutional Therapeutics Discovery Institute, New York, NY, United States

Article metrics

View details

985

Views

586

Downloads

In the original article, there was an error in Table 1 as published. In this table, the chemical structures of TDI-11861 and TDI-11155 were incorrect as the chloro and amino groups of the pyrimidine were drawn in the incorrect positions. In the correct chemical structures, the chloro and amino groups are located at the 4- and 2-positions, respectively. The corrected Table 1 appears below.

TABLE 1

sAC inhibitor structureStandard assay IC50 (nM)Subnanomolar assay IC50 (nM)Cellular (4-4) IC50 (nM)
LRE13238n/d5266
TDI-10229159194114
TDI-11155111116
TDI-11861≤2.51.75
TDI-11893≤2.51.719
TDI-11891≤2.50.332.3

In Vitro Biochemical and Cellular Potency of sAC Inhibitors.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

soluble adenylyl cyclase, male contraceptive, residence time, drug development, picomolar potency, binding kinetics, lead optimization, SPR

Citation

Rossetti T, Ferreira J, Ghanem L, Buck H, Steegborn C, Myers RW, Meinke PT, Levin LR and Buck J (2023) Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential. Front. Physiol. 14:1163389. doi: 10.3389/fphys.2023.1163389

Received

10 February 2023

Accepted

21 February 2023

Published

06 March 2023

Volume

14 - 2023

Edited and reviewed by

Muhammad Aslam, University of Giessen, Germany

Updates

Copyright

*Correspondence: Lonny R. Levin,

This article was submitted to Cell Physiology, a section of the journal Frontiers in Physiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics